Carl L. Gordon - Jun 16, 2022 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director, 10%+ Owner
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Carl Gordon
Stock symbol
TERN
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/21/2022, 09:00 PM
Previous filing
Jun 15, 2022
Next filing
Aug 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to Buy) Award $0 +32K $0.00 32K Jun 16, 2022 Common Stock 32K $1.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant.